I have heard Silviu say that a number of times, and each time I took it as him referring to non-dilutive funding from new partnership deals.
If he specifically said that capital raised from the Kentgrove facility would be non-dilutive, can you please provide where you got that from as I would find that most interesting.
To demonstrate my point, refer to the 1 July 2016 announcement when details of Kentgrove facility was announced, there was again another reference to non-dilutive equity, however not in reference to the Kentgrove facility.
"During this period the Company anticipates key data readouts from each of its Tier 1 programs. In parallel, Mesoblast will continue discussions with potential strategic partners to deliver non-dilutive funding." Extract from 1 July 2016 company update
Morningstar $2.10 valuation, page-33
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.030(2.27%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.28 | $688.1K | 532.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 13548 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 38572 | 7 |
View Market Depth
| Last trade - 11.21am 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |